Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
This study has been completed.
Sponsor:
New York University School of Medicine
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01372644
First received: June 9, 2011
Last updated: June 14, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |